Simcere Pharmaceutical Group Limited Share Price
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
09:08:35 22/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 10.38 HKD | -4.51% |
|
-4.60% | -13.28% |
| 10-19 | Roche Partners With China's Hansoh in Deal That Could Top $15 Billion -- Update | DJ |
| 10-19 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 3.4B 26.66B 3.04B 2.8B 2.55B 4.77B 322B 4.85B 33.75B 13.29B 169B 12.77B 12.5B 535B | P/E 2026 * |
12.8x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.2B 25.11B 2.86B 2.64B 2.4B 4.5B 304B 4.57B 31.79B 12.52B 159B 12.03B 11.77B 504B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.86x |
| Free-Float |
33.7% | Yield 2026 * |
4.08% | Yield 2027 * | 4.63% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
OTC Markets
| SMHGF | Delayed | |
|
Tradegate
| S2P | Real-time | |
|
Deutsche Boerse AG
| S2P | Delayed | |
|
Börse Stuttgart
| S2P | Delayed | |
|
Boerse Muenchen
| S2P | Real-time |
| 1 day | -4.51% | ||
| 1 week | -4.60% | ||
| Current month | -12.41% | ||
| 1 month | -10.59% | ||
| 3 months | -21.18% | ||
| 6 months | -18.91% | ||
| Current year | -13.28% |
| 1 week | 10.33 |  | 11.29 |
| 1 month | 10.33 | | 11.89 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.38 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 19/08/2026 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 24/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 18/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 07/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 18/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 31/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Other | Chairperson | -3,000,000 | 0.1168% | ||
| 13/07/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/07/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.51% | -4.60% | -19.91% | +63.46% | 3.56B | |
| +2.90% | +4.86% | +61.54% | +127.59% | 1,133B | |
| +4.37% | +6.34% | +39.59% | +77.90% | 621B | |
| -0.05% | +0.44% | +24.48% | +96.68% | 503B | |
| +0.03% | +3.27% | +39.79% | +65.06% | 379B | |
| -0.68% | +2.13% | +69.25% | +43.47% | 370B | |
| +1.58% | +2.37% | +22.91% | +52.52% | 292B | |
| +2.90% | +2.22% | +3.51% | +28.51% | 262B | |
| +2.37% | +3.45% | +51.71% | +64.44% | 237B | |
| +2.22% | -0.27% | +29.22% | +102.35% | 190B | |
| Average | +1.08% | +2.88% | +32.21% | +72.20% | 399.15B | |
| Weighted average by Cap. | +1.98% | +3.73% | +43.26% | +85.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.51B 11.83B 1.35B 1.24B 1.13B 2.12B 143B 2.15B 14.97B 5.9B 74.91B 5.67B 5.54B 237B | 1.76B 13.77B 1.57B 1.45B 1.31B 2.47B 166B 2.5B 17.43B 6.87B 87.2B 6.6B 6.45B 276B |
| Net income | 257M 2.01B 229M 211M 192M 360M 24.32B 366M 2.55B 1B 12.74B 964M 943M 40.36B | 303M 2.38B 271M 250M 227M 426M 28.75B 433M 3.01B 1.19B 15.06B 1.14B 1.11B 47.71B |
| Net Debt | -197M -1.55B -176M -162M -148M -277M -18.69B -281M -1.96B -771M -9.79B -741M -725M -31.02B | -140M -1.1B -125M -115M -105M -196M -13.24B -199M -1.39B -546M -6.94B -525M -513M -21.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/10/26 | HK$10.38 | -4.51% | 5,828,700 |
| 21/10/26 | HK$10.87 | -0.64% | 2,100,000 |
| 20/10/26 | HK$10.94 | -0.73% | 2,445,000 |
| 16/10/26 | HK$11.02 | +1.75% | 5,801,000 |
| 15/10/26 | HK$10.83 | -0.46% | 3,387,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
